BioHealth News Archive
BioBuzz Happy Hour – March 20, 2013 at Gaithersburg Growlers
Join us on March 20 at Growlers for another BioBuzz Happy Hour Join our sponsors, BioHealth Innovation, Inc. (BHI) and the Johns Hopkins University Center for…
Read More
Welcome, @Sebelius, to the world of 140 characters – MedCity News
She sent her first tweet just after noon, and already Kathleen Sebelius (@Sebelius) has 2,000-plus followers. The secretary of U.S. Health and Human Services…
Read More
Johns Hopkins among the top schools in world reputation ranking – bmoremedia.com
Johns Hopkins University generally does well on U.S. rankings of the top colleges. But how does it stack up against institutions of higher learning…
Read More
VIDEO: Novavax CEO Stanley Erck Speaks to Company’s Exciting Future
Montgomery County-based Novavax is a biopharmaceutical company creating nanoparticle vaccines targeting a wide array of infectious diseases. In this new video, CEO Stanley Erck…
Read More
Gray: Angel tax credit will be policy ‘focal point’ this year – Washington Business Journal
A tax measure that would create a new, more lenient capital gains rate for tech investors and entrepreneurs cashing out their stock in the…
Read More
The Most Innovative Businesses in DC – Business Insider
Washington, D.C., is known for its cut-throat politics and its power players. What many do not know is that D.C. is now a hub…
Read More
New Enterprise Associates Joins $48M Series C For Nevro – Baltimore Citybizlist
Nevro Corp., a medical device company focused on improving pain relief in patients suffering from debilitating chronic pain, today announced it has completed a $48…
Read More
Personal Genome Diagnostics Inc. Licenses Genome-Mapping Technology from Johns Hopkins University and Expands Its Cancer Genome Analysis Business
Personal Genome Diagnostics Inc. (PGDx), a pioneer in conducting patient-specific analyses aimed at identifying genomic alterations in tumors, today announced a number of developments…
Read More
GSK submits albiglutide for European approval – PMLiVE
GlaxoSmithKline (GSK) has submitted its albiglutide once-weekly injection for type 2 diabetes to European regulators. If approved the biologic treatment, which was submitted for…
Read More
The Promise — and Perils — of Personalized Medicine
Personalized medicine -- the ability to tailor therapies to patients' individual genetic characteristics -- has long been the holy grail of the life sciences…
Read More
University of Maryland ranks in top 100 globally – Washington Business Journal
The University of Maryland, College Park has cracked the top 100 global reputation ranking by a publication based in the United Kingdom, The Washington…
Read More
Nanomedicines Alliance Industry Symposium
NANOMEDICINES: CHARTING A ROADMAP TO COMMERCIALIZATION On 6-7 March 2013, the Nanomedicines Alliance will be holding a Industry Symposium: Charting a Road to Commercialization. The…
Read More
Six HIT heavy-hitters announce interoperability organization | Healthcare IT News
Big news was made at HIMSS13 on Monday when, in an unprecedented collaboration, some health IT heavy-hitters joined forces in an effort to push…
Read More
University Startups Conference 2013: Registration
NOW IN ITS 7th YEAR! University Startups Showcase and Conference 2013 March 20-22, 2013 Washington Convention Center, Washington, D.C. "Corporate Venture Capital and University…
Read More
SR One Steady Amid Health-Care Slump – Venture Capital Dispatch – WSJ
Venture investment in health care cratered in 2012. While others cut back, SR One charged ahead. The venture arm of GlaxoSmithKline formed in 1985…
Read More